Previous 10 | Next 10 |
Pacira BioSciences, Inc. (PCRX) Q1 2020 Results Earnings Conference Call May 07, 2020, 08:30 AM ET Company Participants Susan Mesco - Head of Investor Relations David Stack - Chairman and Chief Executive Officer Charles Reinhart III - Chief Financial Officer Conference Call Pa...
Image source: The Motley Fool. Pacira BioSciences, Inc. (NASDAQ: PCRX) Q1 2020 Earnings Call May 8, 2020 , 8:30 p.m. ET Operator Continue reading
Pacira Pharmaceuticals (NASDAQ: PCRX ): Q1 Non-GAAP EPS of $0.53 beats by $0.23 ; GAAP EPS of $0.19 beats by $0.10 . More news on: Pacira BioSciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
-- Total revenues increased 16 percent over prior year first quarter -- -- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today re...
-- Veteran Industry Executive and Anesthesiologist Brings Significant Clinical and Commercial Experience in Pain Management -- PARSIPPANY, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), a leading provider of innovative non-opioid pain management options...
PARSIPPANY, N.J., April 30, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Thursday, May 7, 2020. Following the release, the company will host a live conference ca...
The FDA has accepted for review a marketing application from privately held Innocoll Holdings Limited seeking approval of Xaracoll (bupivacaine hydrochloride collagen-matrix implants) for the management of postsurgical pain after inguinal (groin) hernia surgery. The agency's action date is...
Ascendis Pharma (NASDAQ: ASND ) initiated with Outperform rating with a $199 (97% upside) price target at Oppenheimer. More news on: Ascendis Pharma A/S, Livongo Health, Inc., Cardinal Health, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. Pacira BioSciences, Inc. (NASDAQ: PCRX) Q4 2019 Earnings Call Feb. 20, 2020 , 8:30 a.m. ET Operator Continue reading
PARSIPPANY, N.J., March 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 Barclays Global Healthcare Conference at 9:00 AM ET on Thursday, March 12, 2020. Live audio of the event can be accessed by visiting the “E...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results after the close of the U.S. markets on Tuesday May 7, 2024. Following the release, the company will host a live conference call and webcas...
2024-04-23 18:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 11:15:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Underperform. PCRX was trading at $28.44 at issue of the analyst recommendation. The overall analyst consensus : BU...